ArticleEndocrine2026
Determinants of physicians' risk-benefit perceptions of adjuvant radioactive iodine for differentiated thyroid cancer.
Carlos Garcia-Regal et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it